Austria 2 – 1 N Ireland

first_imgFTFull TimeAETAfter Extra TimeLIVEThis is a live match.ETExtra TimeHTHalf Time – Advertisement – 7:45pm, Sunday 15th November 2020.Ernst-Happel-Stadion.center_img Austriavs Northern Ireland. UEFA Nations League Group B1.- Advertisement –last_img

FDA approves using Relenza to prevent flu

first_imgMar 29, 2006 (CIDRAP News) – The US Food and Drug Administration (FDA) today approved the use of the antiviral drug zanamivir (Relenza) to prevent—not just treat—influenza in adults and children aged 5 and older.Zanamivir, one of the two flu drugs known as neuraminidase inhibitors, was approved in 1999 for treating flu in people aged 7 and older, but not for prophylactic use. The other neuraminidase inhibitor, oseltamivir (Tamiflu), was approved for both treatment and prevention in adults and children from the age of 1 year.”This approval is a welcome addition to the available defenses against the flu,” Dr. Steven Galson, director of the FDA’s center for Drug Evaluation and Research, said in an FDA news release. “This new use offers the medical community another option to prevent and control influenza A and B.”Many countries are stockpiling oseltamivir, made by Roche, in the hope that it will offer some help in the next flu pandemic. Stockpiling of zanamivir, made by GlaxoSmithKline, has been less prevalent, but the United States is stocking up on both.”We have purchased, as of today, 4 million treatment courses of Relenza and 22 million treatment courses of Tamiflu,” Bill Hall, a spokesman for the Department of Health and Human Services, told CIDRAP News today. “We expect all of them to be in the stockpile by the end of this calendar year.”Hall said HHS is aiming for a total of 81 million treatment courses of the two antivirals by 2008, with zanamivir making probably up about 20%.Zanamivir is a powder that is inhaled by mouth with a “Diskhaler” device. Oseltamivir comes in capsule form.Four large, placebo-controlled studies have shown the effectiveness of Relenza for preventing flu, the FDA reported. In two trials, the incidence of flu in households whose members received the drug was 4.1%, versus 19.0% in households where people received a placebo.In a third trial, involving only adults, 2.0% of people in the Relenza group experienced flu symptoms, versus 6.1% of those in the placebo group, the FDA reported. In the fourth study, which involved mostly older adults, flu symptoms occurred in 1.4% of placebo group members and 0.2% of the treatment group.The FDA said zanamivir has not been found effective for preventing flu in nursing homes. Also, it is not recommended as a substitute for flu vaccine, the primary tool for preventing flu.The drug is not recommended for people who have asthma or other chronic respiratory disease, the FDA noted. After zanamivir’s initial approval, bronchospasm, in some cases fatal, was reported in some patients, most of whom had asthma or chronic obstructive pulmonary disease, the agency said.See also:Mar 29 FDA news releasehttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108622.htmFDA background information on Relenzahttp://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm183783.htmGlaxoSmithKline’s detailed information on Relenzahttp://us.gsk.com/products/assets/us_relenza.pdfCIDRAP overview on use of antiviral agents for pandemic flulast_img read more

Bill to Bulldoze CPO injustice

first_imgWould you like to read more?Register for free to finish this article.Sign up now for the following benefits:Four FREE articles of your choice per monthBreaking news, comment and analysis from industry experts as it happensChoose from our portfolio of email newsletters To access this article REGISTER NOWWould you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week.last_img

Over 500 Jamaican cataract patients to receive free eye surgery from…

first_imgKINGSTON, Jamaica, Mar. 24, CMC – Over 500 Jamaicans are to benefit from cataract surgeries at the Kingston Public Hospital (KPH), to be performed by Chinese ophthalmologists from the Bright Journey Medical Mission.Providing equipment, supplies to KPHThe Mission, which will be on their second visit to the island, will also be providing equipment and supplies valued at J$52.9 million to KPH and carrying out training and lectures in ophthalmology, and facilitating academic exchanges.This was disclosed by Permanent Secretary in the Ministry of Health, Dunstan Bryan at a recent signing ceremony for a Memorandum of Understanding (MOU) for the mission between Jamaica and the People’s Republic of China.According to the Permanent Secretary, China has been one of Jamaica’s strongest development partners with diplomatic relations extending over several decades.“In recent times, Jamaica’s collaboration with China has been especially robust in health. That collaboration is on show with the signing of an MOU that heralds a deepening of our partnership and in the public health interest,” he said.The Bright Journey Medical Mission is scheduled to return to Jamaica in April, following its first visit in May 2015. The team includes ophthalmologists, nurses and technical support staff from the Beijing Friendship Hospital, Capital Medical University and the Beijing Municipal Health Commission.“This initiative is a clear demonstration of a strong and healthy bilateral relationship between [both countries] in the area of Public Health. The government and people of Jamaica extend thanks to the government and people of the Peoples Republic China for their generosity and longstanding friendship,” the Permanent Secretary said.He added that the relationship has allowed several Jamaicans to have an improved quality of life through restoration of vision and a happier life.For his part, Chinese Ambassador to Jamaica, Tian Qi said the cooperation in the health, is one of the major areas of partnership between Jamaica and China.“Our cooperation is comprehensive and mutually beneficial in nature and with this second Bright Journey, they will perform at least 500 cataract surgeries for patients here and restore their sight. It is a gesture of goodwill of the Chinese government and the people through the Jamaican government and the people,” he said.last_img read more